Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China ...

Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will add ...

There are many types of allergy eyedrops. Not all treat all allergy symptoms. For example, one that relieves red eyes may not stop the itching. Some are sold over the counter. For others you need ...

ZERVIATE is the first and only eye drop formulation of the antihistamine cetirizine, the active ingredient in ZYRTEC ®, and is currently commercialized in the U.S. for ocular itching associated ...

ZERVIATE® (cetirizine ophthalmic solution) 0.24%, a histamine-1 (H1) receptor antagonist indicated for treating ocular itching associated with allergic conjunctivitis.

Eye care pharmaceutical company Harrow announced the completed transfer of new drug applications for Flarex, Natacyn, Tobradex ST, Verkazia and Zerviate, all of which were acquired in July and ...

A high-level overview of Harrow, Inc. NT CAL 27 (HROWM) stock. View (HROWM) real-time stock price, chart, news, analysis, analyst reviews and more.